CYNBIOSE est membre de Lyonbiopôle

General information

1, avenue Bourgelat

69280 Marcy l'Etoile

Incorporated in: 2008/10/25

Number of employees: 16

Turnover: €2M (in 2018)


Main activity

Cynbiose is a specialty preclinical CRO offering research services with a core expertise and focus on the non-human primate (NHP) model.


Public funding obtained: Public funding obtained: CYBIOME : the project has procured financing of €1.9 million under the third phase of the French Program ‘Investment for the Future’ (PiA3). CYNBIOME™ is financed by the French government and the Auvergne-Rhône-Alpes region and is supported by Bpifrance (The French Public Bank of Investment).

Products / Services / Technologies

Strategic area of application
Human Medicine

Application market
Cardiology - Immune, AutoIm & Inflam. diseases - Infectiology - Parasitology - Neurological diseases - Oncology - Pneumology

Therapeutics, Pharma or Biotech - Medical device

Design & Modelling studies - Vaccine - Antibodies - Protein - Peptide - Others